Deep Intelligence Across Industries

Company Headquarters: New York, US Founded: 1988 Workforce: ~1,200 Company Working: AngioDynamics manufactures disruptive and innovative medical devices. The company provides vital tools to healthcare professionals around the world. It reaches over 50 markets via direct sales and distributors. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. AngioDynamics has operating facilities in Europe, the US, Asia, and Latin America.

Company Headquarters: Vaulx-en-Velin, France Founded: 1979 Workforce: ~ 500 Company Working: EDAP TMS is a pioneer and a market leader in Extracorporeal ShockWave Lithotripsy (ESWL) with the Sonolith range of devices. Its products are marketed through a network of subsidiaries and distribution partners around the globe. It is investing in R&D heavily to maintain and strengthen its level of innovation and research. It also offers three HIFU products such as the Ablatherm, Ablatherm Fusion, and Focal One. Products including lasers, micro-ultrasound equipment, and other medical supplies are sold by its distribution division to support its international activities. The company has operations in France, the US, and other regions.

Company Headquarters: Mumbai, India Founded: 1968 Workforce: ~18,302 Company Working: Lupin Pharmaceuticals, Inc., a multinational pharmaceutical company, manufactures and distributes drugs. It develops and produces branded and generic formulations, biotechnology goods, and pharmaceutical active components. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars, and Complex Injectables. The vast majority of the company's sales are generated in the US, followed by India. In addition, Lupin creates generic drugs with added value using its platform technology. Furthermore, the business runs production facilities in Brazil, Mexico, the US, and India together with its subsidiaries.

Company Headquarters: Germany Founded: 1946 Workforce: ~ 1,959 Company Working: Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. Biotest AG develops, manufactures, and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies. Barcelona-based Grifols, a global leader in plasma-derived medicines, today announced the completion of the acquisition of Biotest AG, a European healthcare company specialized in innovative hematology and clinical immunology.

Company Headquarters: Italy Founded: 2000 Workforce: ~1,050 Company Working: Kedrion S.p.A. develops and distributes plasma-derived medicinal products. The Company produces plasma-derived products for use in treating serious diseases, disorders, and conditions such as hemophilia and immune system deficiencies. Kedrion serves customers worldwide. Kedrion is a biopharmaceutical company that specializes in the development, production, and distribution of plasma-derived therapeutic products for use in treating serious diseases, disorders, and conditions such as immune system deficiencies and coagulation disorders. The company operates through a fully integrated business model from the collection of plasma in its own centres in the United States to fractionation and production in its manufacturing facilities located in Italy, Hungary, and North America. Headquartered in Castelvecchio Pascoli (Lucca, Italy), Kedrion has approximately 2,800 employees and a commercial presence in 100 countries worldwide.

Company Headquarters: USA Founded: 1931 Workforce: 60000 Company Working: Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals, and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision. Baxter is a scientific leader and innovator in plasma-derived therapies, with a focus on providing solutions to unmet patient needs. Its products include an immunoglobulin therapy (IG) for people living with primary immunodeficiency (PI), albumin therapies used to treat burns and maintain adequate fluid volume in critically ill patients, as well as blood protein therapies for people suffering from alpha-1 antitrypsin deficiency.

Company Headquarters: Spain Founded: 1909 Workforce: ~ 4,763 Company Working: Grifols Therapeutics, Inc. operates as a biotherapeutic and biotechnology company. The Company discovers, develops, and produces critical care treatment products for the people with life-threatening disorders. Grifols Therapeutics serves patients, hospitals, pharmacies, and healthcare professionals worldwide. Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing, and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies. Grifols' plasma fractionation capacity is 3.6 million liters of plasma a year and is carried out in the company's two plants located in Parets del Valles (Barcelona) and Los Angeles.

Company Headquarters: Oregon, US Founded: 2005 Workforce: 85 Company Working: Medical Marijuana, Inc. is the world’s first legal supplier of cannabidiol products. Medical Marijuana Inc. is a holding company that operates through its various subsidiaries such as Kannaway, LLC, HempMeds Brasil, Canchew Biotechnologies LLC, HempMeds PX, LLC, The Hemp Network, Canipa Holdings, aNew Chocolate, LLC, MJNA Investment Holdings, LLC, and Dixie Elixirs, LLC. The company’s focus area includes the creation of the international CBD pipeline, the manufacture of legal cannabis consumer products and cannabis drugs, the development of new markets for medical cannabis, and the provision of support services for the cannabis industry. It is the first company to deliver prescription CBD products for various health applications such as Alzheimer’s disease, Epilepsy, Parkinson’s disease, chronic pain, and migraine. Additionally, in 2017, HempMeds, the international subsidiary of Medical Marijuana, Inc., became the first company to have a cannabis-based product, RSHO-X, subsidized by a government in Mexico.

Company Headquarters: UK, Europe Founded: 2012 Workforce: ~ 500 Company Working: Exscientia is a global pharma tech company using patient-first AI, drug discovery, and design enterprise. The company offers its products under the category of the precision target, precision design, precision experiment, and precision medicine. Moreover, the company platform has delivered the first three AI-system to improve clinical outcome in oncology. The company has strong business presence in Europe region.